4.14 million. 2. The cost of medical treatments when compared to income from medical treatments decreased 5.06% due to the cost of medical treatments from CMR went down 9.00% and the cost of medical
from the same period of last year due to loss on forward contract caused by foreign exchange volatility during the Covid-19 pandemic. 1.2 Cost of goods sold and expenses Consolidated financial statements
. The cost of medical treatments when compared to income from medical treatments decreased 5.06% due to the cost of medical treatments from CMR went down 9.00% and the cost of medical treatments in the
cost of sales being the most frequently recurring themes. Many different factors may have led to such persistent deficiencies of some audit firms and auditors. This includes insufficient involvement of
in the 2H17 are expected to continue in 2018 with most of the volumes contracted. These margins are not yet at 2015 levels due to higher cost IPA and MEG seen in 2017 and continuing in 2018 although
during first half of 2017. However, the increasing in domestic sales push up the total revenue becoming minor decreasing. Cost of goods sold of Q3/17 is increased by 5.86% comparing with Q2/17 and 7.82
Operating results of the Company for the three-month period ended 31 March 2019 and 2018 are as follows: Revenue by segment Revenue Cost Gross Profit For three-month period ended 31 March For three-month
was stagnant, the food sales for Q2’2018 was Baht 1,607 million, increased by Baht 13 million or 0.8% from Q2’2017 mainly from continued store expansion. Cost of Sales Total cost of sales of the company
Details of the costs involving to the WTGs foundation improvement for Huay Bong 2&3 Wind Farm at September 30, 2017 are as shown in the table. Description Estimated total improvement cost (until year 2016